SEC Company Response from AETHLON MEDICAL INC (AEMD) (CIK 0000882291) (AEMD) — Dec 11, 2019

AETHLON MEDICAL INC (AEMD) (CIK 0000882291)
Date: Dec. 11, 2019 · CIK: 0000882291 · Accession: 0001683168-19-003946

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-234712

Date

December 12, 2019

Author

H.C. WAINWRIGHT & CO., LLC

Form

CORRESP

Company

AETHLON MEDICAL INC (AEMD) (CIK 0000882291)

Letter

Re: AETHLON MEDICAL, INC.

December 11,

VIA FACSIMILE AND EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Washington, D.C. 20549

Registration Statement on Form S-1 (Registration No. 333-234712)

Concurrence in Acceleration Request

Ladies and Gentlemen:

H.C. Wainwright & Co., LLC (“Wainwright”), as managing underwriter for the above-referenced offering, hereby concurs in the request by Aethlon Medical, Inc. that the effective date of the above-referenced registration statement be accelerated to 5:15 P.M. Eastern Time on Thursday, December 12, 2019, or as soon as practicable thereafter, pursuant to Rule 461 under the Securities Act. Wainwright affirms that it is aware of its obligations under the Securities Act in connection with this offering.

Very truly yours,
H.C. WAINWRIGHT & CO., LLC

Show Raw Text

CORRESP
1
filename1.htm

December 11,
2019

VIA FACSIMILE AND EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Washington, D.C. 20549

 Re: AETHLON MEDICAL, INC.

    Registration Statement on Form
S-1 (Registration No. 333-234712)

    Concurrence in Acceleration Request

Ladies and Gentlemen:

H.C. Wainwright &
Co., LLC (“Wainwright”), as managing underwriter for the above-referenced offering, hereby concurs in the request
by Aethlon Medical, Inc. that the effective date of the above-referenced registration statement be accelerated to 5:15 P.M. Eastern
Time on Thursday, December 12, 2019, or as soon as practicable thereafter, pursuant to Rule 461 under the Securities Act. Wainwright
affirms that it is aware of its obligations under the Securities Act in connection with this offering.

    Very truly yours,

    H.C. WAINWRIGHT & CO., LLC

    By: /s/ Edward D. Silvera

    Name: Edward D. Silvera

    Title: Chief Operating Officer

SecProbe.io